TY  - GEN 
AU  - Mesquita Ramírez, Mirta
AU  - Samudio, Margarita
AU  - Cardozo Sarubbi, Olivia Carolina
AU  - Carrera Vargas, Dina Carmen
AU  - Villalba Cabral, Pedro Luis
A4  - Universidad Católica Nuestra Señora de la Asunción
PY  - 2023
SN  - 2249-4847
UR  - http://hdl.handle.net/20.500.14066/4507
AB  - Introduction: 
Treatment of severe persistent pulmonary hypertension of the newborn (PPHN) is based on the administration of selective pulmonary vasodilators. Inhaled nitric oxide is the only vasodilator therapy approved by the Food and Drug...
LA  - eng
PB  - Wolters Kluwer - Medknow Publications
KW  - 7. Salud
KW  - 7.4. Seguimiento sanitario
KW  - Citrato de sildenafil
KW  - Lactante
KW  - Óxido nitroso
KW  - Recién nacido
KW  - Síndrome de circulación fetal persistente
KW  - Vasodilatadores
KW  - Sildenafil citrate
KW  - Infant
KW  - Nitrous oxide
KW  - Newborn
KW  - Persistent fetal circulation syndrome
KW  - Vasodilator agents
KW  - Oxygenation index
KW  - Persistent pulmonary hypertension of the newborn
KW  - Sildenafil
TI  - Intravenous sildenafil for the treatment of persistent pulmonary hypertension of the newborn in a resource-limited setting
DO  - 10.4103/jcn.jcn_33_23
VL  - 12
ER  -